KR100767802B1 - Functional beverage containing persimmon vinegar - Google Patents

Functional beverage containing persimmon vinegar Download PDF

Info

Publication number
KR100767802B1
KR100767802B1 KR1020060061065A KR20060061065A KR100767802B1 KR 100767802 B1 KR100767802 B1 KR 100767802B1 KR 1020060061065 A KR1020060061065 A KR 1020060061065A KR 20060061065 A KR20060061065 A KR 20060061065A KR 100767802 B1 KR100767802 B1 KR 100767802B1
Authority
KR
South Korea
Prior art keywords
persimmon vinegar
vinegar
persimmon
fermentation
acetic acid
Prior art date
Application number
KR1020060061065A
Other languages
Korean (ko)
Inventor
차연수
최동성
오석흥
문연정
Original Assignee
전북대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전북대학교산학협력단 filed Critical 전북대학교산학협력단
Priority to KR1020060061065A priority Critical patent/KR100767802B1/en
Application granted granted Critical
Publication of KR100767802B1 publication Critical patent/KR100767802B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12JVINEGAR; PREPARATION OR PURIFICATION THEREOF
    • C12J1/00Vinegar; Preparation or purification thereof
    • C12J1/04Vinegar; Preparation or purification thereof from alcohol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • A23L2/382Other non-alcoholic beverages fermented
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • C12N1/185Saccharomyces isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces
    • C12R2001/865Saccharomyces cerevisiae

Abstract

A health functional drink comprising persimmon vinegar obtained by the alcohol fermentation and acetic acid fermentation is provided to decrease abdominal fat and secure the function of lowering cholesterol in blood and blood sugar, thereby being used as foods for effectively inhibiting or preventing obesity. A health functional drink comprising persimmon vinegar is obtained by a method comprising the steps of: (a) adding 1-10 wt.% of Saccharomyces baynus, 30-80 ppm of pectinase and sugar to crushed material of persimmon; (b) subjecting the mixture of the step (a) to the enzymatic reaction for 10-14 hours at room temperature; (c) subjecting the product obtained from the step (b) to the alcohol fermentation at a temperature of 24-26 deg.C for 3-10 days with blocking air; (d) ripening the product of the step (c) at a temperature of about 15 deg.C for 1-2 months; and (e) after adding 1-10 wt.% of persimmon vinegar containing acetobacter to a fermented solution obtained by filtering the alcohol fermented solution, subjecting it to the acetic acid fermentation at a temperature of 15-20 deg.C for 30-45 days.

Description

감식초를 함유하는 건강 기능성 음료 {Functional beverage containing Persimmon Vinegar}Functional beverage containing persimmon vinegar {Functional beverage containing Persimmon Vinegar}

도 1은 공복시 혈당 변화를 그래프로 나타낸 것이다.1 is a graph showing the change in fasting blood glucose.

도 2는 경구 당 부하 검사를 그래프로 나타낸 것이다. Figure 2 graphically shows the oral glucose tolerance test.

본 발명은 항비만용 감식초에 관한 것으로, 더욱 상세하게는 알코올 발효와 초산발효의 2단 발효법에 의해 얻은 항비만용 감식초 및 이를 함유하는 건강 기능성 음료에 관한 것이다.The present invention relates to anti-obesity persimmon vinegar, and more particularly, to an anti-obesity persimmon vinegar obtained by the two-stage fermentation method of alcohol fermentation and acetic acid fermentation, and a health functional beverage containing the same.

최근 교통수단의 발달 및 산업화에 따라 생활양식이 변화되고 식생활이 서구화됨에 따라 현대인들이 음식물로부터 섭취하는 각종 열량원의 양은 증가하는 반면 운동량은 감소되어 영양 과잉 및 영양 불균형으로 인하여 비만 인구가 증가하고 각종 성인병 발병률이 급증하고 있으며, 이러한 변화는 향후 전체 국민 건강을 위협할 정도로 사회적으로 심각한 문제를 야기할 수 있다. 비만은 단순히 외형상의 문 제뿐 만 아니라 비만이 지속됨으로써 여러 가지 질환, 즉, 고혈압, 당뇨, 고지혈증, 관상동맥질환 등과 같은 성인성 질병을 비롯하여 유방암, 자궁암 및 대장암 등을 야기하는 것으로 보고되면서 이제는 치명적인 질병 중 하나로 취급되고 있다[J. Biol. Chem., 273, 32487 ∼ 32490 (1998); Nature, 404, 652 ∼ 660 (2000)].With the recent development of transportation and the development of industrialization, lifestyle changes and dietary lifestyles have increased, the amount of calorie sources that modern people consume from food increases, but the amount of exercise decreases, resulting in an increase in obesity and an increase in obesity. The incidence of adult diseases is increasing rapidly, and these changes can cause serious social problems that threaten the health of the public in the future. Obesity is now fatal as it is reported to cause not only cosmetic problems but also obesity, causing various diseases such as hypertension, diabetes, hyperlipidemia and coronary artery disease, as well as adult diseases such as breast cancer, uterine cancer and colon cancer. Treated as one of the diseases [J. Biol. Chem., 273, 32487-32490 (1998); Nature, 404, 652-660 (2000).

이와 같이 비만이 현대 사회의 문제로 대두되면서, 많은 사람이 비만을 예방하고 치료하기 위한 다이어트 방법에 큰 관심을 보이게 되었다.As obesity emerged as a problem of modern society, many people became interested in dieting methods to prevent and treat obesity.

비만은 과잉 영양성분이 연소되지 않고 체내에 지방으로 축적되는 데서 기인하는데, 비타민, 미네랄, 효소와 같은 영양 조절인자가 풍부하면 인체의 신진대사가 촉진되어 체내 지방 축적을 방지할 뿐 아니라 축적된 지방을 배출할 수 있게 된다. 현재까지 알려진 비만 예방이나 치료를 위한 다이어트 방법으로 식사요법, 운동요법, 행동수정요법 등이 있는데, 특히, 식사요법이 비만 치료에서 가장 근본적이며 중요하다. 바람직한 식사요법은 섭취 열량을 줄이고 소모를 증가시킴으로써, 체내 축적된 지방을 분해할 수 있어야 한다. 그러나 현실적으로 식행동은 변경되기가 매우 어렵고, 식품 교환군을 고려하여 식사를 한다는 것은 현대인들에게 대단히 어려운 일이다.Obesity is caused by the accumulation of excess nutrients as fat in the body rather than burning. Abundant nutritional regulators such as vitamins, minerals, and enzymes promote the body's metabolism to prevent the accumulation of fat in the body as well as to accumulate fat. Can be discharged. Known diet methods for preventing or treating obesity, such as diet therapy, exercise therapy, behavior modification therapy, etc., in particular, diet therapy is the most fundamental and important in the treatment of obesity. Preferred diets should be able to break down the body's accumulated fat by reducing calories and increasing consumption. However, in reality, eating behavior is very difficult to change, and it is very difficult for modern people to eat with the food exchange group in mind.

따라서 영양학적으로 균형된 식생활을 영위할 수 있도록 도우면서, 동시에 효율적으로 체지방을 감소할 수 있도록 하는 건강식품 등의 개발이 요구되고 있다.Therefore, there is a need for development of health foods such as helping to maintain a nutritionally balanced diet and at the same time efficiently reducing body fat.

감식초는 옛날부터 일반 농가에서 제조하여 이용되어온 전통발효식품으로 숙취제거, 피로회복 및 정장작용 등의 민간요법에 애용되어 왔다. 최근 급격한 경제성장 및 건강에 대한 인식전환으로 천연소재의 전통양조식초에 대한 관심이 높아져 상품으로 시판되어 유통되고 있는 감식초는 수확된 감을 장기간이 소요되는 복발효의 자연발효에 의해 출하되고 있다. Persimmon vinegar is a traditional fermented food that has been manufactured and used by farmers since ancient times, and has been used for folk remedies such as hangover removal, fatigue recovery, and dressing. Recently, due to the rapid economic growth and the shift in awareness of health, persimmon vinegar is being marketed as a commodity due to increased interest in traditional brewed vinegar of natural materials.

또한, 식초는 잘 알려진 바와 같이, 대표적인 초산발효 식품으로서 기초조미료로서 오랜 역사를 가지고 있고 나라마다 대표적인 술을 원료로 하여 식초를 양조하고 있다. 식초는 최근 들어 건강 기능성 식품으로도 각광받고 있는데, 당뇨, 고혈압, 동맥경화, 비만과 같은 성인병은 물론 불면증, 피부미용, 변비 등에도 효험이 있는 것으로 알려지고 있다.In addition, vinegar, as is well known, has a long history as a base seasoning as a typical acetic acid fermented food, and vinegar is brewed using a representative liquor in each country. Vinegar has recently been spotlighted as a health functional food, it is known to be effective in insomnia, skin care, constipation, as well as adult diseases such as diabetes, hypertension, arteriosclerosis, obesity.

한편, 본 발명에서와 같이 감식초를 항비만 식품으로 적용한 예는 아직까지 알려져 있지 않다.On the other hand, as an example of applying persimmon vinegar as an anti-obesity food as in the present invention is not known yet.

본 발명의 목적은 비만의 효율적인 억제 또는 예방을 위하여 알코올 발효와 초산발효의 2단 발효법에 의해 얻은 항비만용 감식초 및 이를 함유하는 건강 기능성 음료를 제공하는데 있다. It is an object of the present invention to provide an anti-obesity persimmon vinegar obtained by the two-stage fermentation method of alcohol fermentation and acetic acid fermentation and a healthy functional beverage containing the same for effective suppression or prevention of obesity.

상기한 목적을 달성하기 위하여 본 발명은 알코올 발효와 초산발효의 2단 발효법에 의해 얻은 항비만용 감식초를 제공한다.In order to achieve the above object, the present invention provides anti-obesity persimmon vinegar obtained by the two-stage fermentation method of alcohol fermentation and acetic acid fermentation.

상기에서, 알코올 발효는 감 분쇄물에 사카로마이세스 베이아누스 효모를 첨가하여 알코올 발효시킨 것임을 특징으로 한다.In the above, the alcohol fermentation is characterized in that the alcohol fermentation by adding Saccharomyces Bayanus yeast to the persimmon grounds.

또한, 상기에서, 초산발효는 발효스타터로 초산균을 함유한 감식초가 사용됨을 특징으로 한다.In addition, acetic acid fermentation is characterized in that the persimmon vinegar containing acetic acid bacteria as a fermentation starter is used.

또한, 본 발명은 상기 감식초를 함유하는 건강 기능성 음료를 제공한다.The present invention also provides a health functional beverage containing the persimmon vinegar.

이하 본 발명의 내용을 더욱 상세하게 설명하면 다음과 같다. Hereinafter, the content of the present invention will be described in more detail.

본 발명의 알코올 발효와 초산발효의 2단 발효법에 의해 얻은 항비만용 감식초는 복부지방을 감소시키는 효과를 나타내며, 혈중 및 간중 지질과 콜레스테롤을 감소시키므로 비만 억제 또는 예방에 효과적이다. Anti-obesity persimmon vinegar obtained by the alcohol fermentation and acetic acid fermentation two-stage fermentation method of the present invention exhibits an effect of reducing abdominal fat, and is effective in inhibiting or preventing obesity because it reduces blood and liver lipids and cholesterol.

본 발명에 의한 감식초는 알코올 발효와 초산발효의 2단 발효법에 의해 제조된 것을 사용하는 것이 바람직하다. Persimmon vinegar according to the present invention is preferably used by the two-stage fermentation method of alcohol fermentation and acetic acid fermentation.

상기 알코올 발효를 위하여 감의 꼭지부분 등의 불필요한 부분을 제거하고 감을 골고루 으깨어 준비하고, 으깨어진 감에 효모균을 첨가하여 알코올 발효를 한다. 알코올발효에 사용되는 효모는 감을 구성하는 각종 발효성 당을 알코올로 전환시키는 능력이 우수한 사카로마이세스 베이아누스를 사용하는 것이 바람직하다. 상기 효모균은 감의 중량을 기준으로 감분쇄물에 대하여 1~10중량%를 첨가하는 것이 좋다. For the alcoholic fermentation, unnecessary parts such as the periphery of persimmons are removed, and the persimmons are evenly crushed, and yeast is added to the crushed persimmon to ferment alcohol. As for yeast used for alcohol fermentation, it is preferable to use Saccharomyces beyanus which is excellent in the ability to convert the various fermentable sugars which comprise persimmon into alcohol. The yeast is preferably added 1 to 10% by weight based on the weight of the persimmon ground based on the weight of persimmon.

상기 효모에 의한 알코올 발효과정의 이전에 또는 동시에 단백질을 분해하기 위한 펙티나아제를 30~80 ppm 정도 더 첨가하는 것이 좋다. 이는 감펄프질을 분해하여 후속공정인 알코올 발효 및 초산 발효공정을 용이하게 하며, 감식초의 수율 증진에도 기여할 수 있다. 펙티나아제를 첨가한 후 효고 반응은 실온에서 10~14시 간 정도 수행하는 것이 좋다. 알코올 발효과정은 공기를 차단한 상태로 24~26℃에서 3~10일 동안 수행하고, 주 발효가 종료된 다음 15℃ 전후의 온도에서 1~2개월 동안 숙성시켜 감 와인을 얻는 것이 바람직하다. Prior to or simultaneously with the alcoholic fermentation process by the yeast, it is preferable to add 30 to 80 ppm more pectinase to decompose the protein. This facilitates the alcoholic fermentation and acetic acid fermentation process subsequent to decomposition of persimmon pulp, and may also contribute to the yield of persimmon vinegar. After adding the pectinase, the Hyogo reaction may be performed at room temperature for about 10 to 14 hours. Alcohol fermentation process is carried out for 3 to 10 days at 24 ~ 26 ℃ with air blocking, it is preferable to obtain persimmon wine by aging for 1 to 2 months at a temperature around 15 ℃ after the main fermentation is complete.

상기 알코올 발효액을 여과하여 얻어진 발효액에 초산균을 함유한 감식초를 1~10중량% 첨가하여 15~20℃에서 30~45일 동안 초산발효를 실시한다. The fermentation broth obtained by filtering the alcohol fermentation broth is added with 1 ~ 10% by weight of persimmon vinegar containing acetic acid bacteria to perform acetic acid fermentation at 15 ~ 20 ℃ for 30 to 45 days.

상기한 바와 같이 2단 발효과정을 거쳐 얻어지는 감식초는 5~10℃에서 충분한 기간 동안 숙성하고 여과하는 과정을 거쳐 최종 감식초를 얻을 수 있다. 바람직하게는 2년 이상 숙성하는 것이 좋다. As described above, the persimmon vinegar obtained through the two-stage fermentation process may be subjected to ripening and filtering for a sufficient period at 5 to 10 ° C. to obtain a final persimmon vinegar. Preferably aged for 2 years or more.

본 발명의 실시예에서 감식초를 C57BL/6J종 수컷 생쥐에게 고지방식이를 먹이면서 몸무게 ㎏당 1㎖~2㎖ 수준으로 경구투여 하였을 때, 복부지방을 감소시키고 혈중 콜레스테롤 및 혈당을 감소시키는 기능이 있으므로, 비만을 효과적으로 억제 또는 예방 식품으로 이용할 수 있다.In the embodiment of the present invention, when the persimmon vinegar is orally administered at a level of 1 ml to 2 ml per kg of body weight while feeding high fat diet to C57BL / 6J male mice, it has a function of reducing abdominal fat and reducing blood cholesterol and blood sugar. Therefore, obesity can be effectively used as a food for suppressing or preventing obesity.

본 발명에 의한 감식초는 함유한 비만 억제 또는 예방 식품으로서, 감식초의 산도는 5~6%인 것이 바람직하다. Persimmon vinegar according to the present invention is an obesity inhibitory or preventive food containing, and the acidity of the persimmon vinegar is preferably 5 to 6%.

또한, 본 발명의 비만 억제 및 예방을 위한 감식초는 건강 기능성 음료의 형태로 제조될 수 있다. 본 발명에 따른 건강 기능성 음료는 감식초 이외에 통상의 음료에 첨가되는 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 포함할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등 디사카라이드, 예를 들어 말토스, 슈크로스 등 및 폴리사카라이드, 예를 들 어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 크실리톨, 소르비톨, 에리트리톨 등의 당알콜이 있다. 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기한 추가 성분 이외에 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 충진제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 포함할 수 있다. 또한, 천연 과일 주스 및 과일 주스 음료 및 야채 음료의 제조를 위한 과육을 포함할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. In addition, persimmon vinegar for the prevention and prevention of obesity of the present invention can be prepared in the form of health functional beverage. In addition to persimmon vinegar, the health functional beverage according to the present invention may include various flavors or natural carbohydrates, etc. which are added to conventional beverages as additional ingredients. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and other disaccharides such as maltose, sucrose and the like and polysaccharides such as dextrin, cyclodextrin and the like And sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents, natural flavoring agents (tauumatin, stevia extracts (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. Various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic and natural flavors, colorants and fillers, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH regulators, stable Topical agents, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, etc. It may also include pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. Or in combination.

이하, 본 발명을 실시예에 의하여 구성 및 효과를 더욱 상세히 설명한다. 그러나 하기 실시예는 본 발명을 예시하는 것으로 본 발명이 이들 실시예에 한정되는 것은 아니다.Hereinafter, the configuration and effect of the present invention in more detail. However, the following examples illustrate the present invention and the present invention is not limited to these examples.

[실시예 1] 감식초의 제조Example 1 Preparation of Persimmon Vinegar

감식초 제조를 위한 감은 전북 완주군의 감골식품에서 고종시를 구입하여 사용하였다. 감의 꼭지를 제거하여 으깬 후 60ppm의 pectinase 처리를 하고 실온에서 12시간 두었다. 여기에 15 brix 설탕을 가미한 후 5% 사카로마이세스 베이아누스(Saccharomyces bayanus) 종배양액을 첨가하여 혼합하여 25℃에서 5일 동안 알코 올 발효가 진행되도록 하였다. 알코올 발효가 끝나면 여과하고 5% 감식초(고산감골식품, 한국)를 스타터로 첨가한 후 밀봉하여 15~20℃에서 초산발효가 일어나도록 하였다. 마지막으로, 여과하여 보관하면서 숙성시켰다. 실험에는 숙성을 시작한 지 8개월 된 초산도 5.22%, 탄닌 0.278%인 감식초를 사용하였다.Persimmon for producing persimmon vinegar was used by purchasing Gojong-si from Gamggol food in Wanju-gun, Jeonbuk. After mashing off the persimmons, 60ppm pectinase treatment was performed and left at room temperature for 12 hours. After adding 15 brix of sugar, 5% Saccharomyces bayanus seed culture solution was added and mixed to allow alcohol fermentation to proceed at 25 ° C. for 5 days. After alcohol fermentation was filtered and 5% persimmon vinegar (Gosan Jalgol Food, Korea) was added as a starter and sealed to allow acetic acid fermentation at 15-20 ℃. Finally, the cells were aged by filtration and stored. Persimmon vinegar with 5.22% acetic acid and 0.278% tannin was used in the experiment for 8 months.

[실시예 2] 동물 실험Example 2 Animal Experiment

실험에 사용된 동물은 출생시기가 동일한 27주령(27 weeks) C57BL/6J 종 수컷 생쥐 (n=32)를 1주일 동안 고형식이(AIN-93)를 급여하여 환경에 적응 시킨 후 난괴법(randomized block design)에 의해 4군, 즉 고지방식이군(HD), 고지방식이+산도 5.2% 양조식초(1㎖/kg BW) 투여군(HD-V), 고지방식이+산도 5.2% 감식초(1㎖/kg BW) 투여군1(HD-PV1) 및 고지방식이+산도 5.2% 감식초(2㎖/kg BW) 투여군2(HD-PV2)로 각각 8마리씩 나누었다. 물과 실험 식이는 자유롭게 섭취하도록 하였다. 사육실의 온도는 23~25℃로 습도는 70~80%로 유지하였으며, 명암은 12시간 주기로 조절하였다. 실험 식이는 Research DietTM사(USA) AIN-93 diet를 변형한 고지방식이(60% fat kcal)를 구입하여 섭취케 하였으며 그 조성은 표 1과 같다.The animals used in the experiment were 27 weeks old C57BL / 6J male mice (n = 32) with the same birth date, and were fed with solid foods (AIN-93) for 1 week to adapt to the environment. 4 groups, high fat diet group (HD), high fat diet + acidity 5.2% Brewed vinegar (1ml / kg BW) group (HD-V), high fat diet + 5.2% persimmon vinegar (1) Eight rats were divided into two groups (ml / kg BW) administration group 1 (HD-PV1) and high-fat diet + acidity 5.2% persimmon vinegar (2ml / kg BW) administration group 2 (HD-PV2). Water and experimental diets were freely consumed. The temperature of the breeding room was maintained at 23 ~ 25 ℃, the humidity was 70 ~ 80%, and the contrast was adjusted every 12 hours. The experimental diet was purchased by eating a high-fat diet (60% fat kcal) modified from Research Diet TM (USA) AIN-93 diet and its composition is shown in Table 1.

하기에서, HD는 고지방식이, HD-V는 고지방식이+산도 5.2% 양조식초(1㎖/kg b.w.), HD-PV1은 고지방식이+산도 5.2% 감식초(1㎖/kg b.w.), HD-PV2는 고지방식이+산도 5.2% 감식초(2㎖/㎏ b.w.)를 나타낸다. In the following, HD is a high fat diet, HD-V is a high fat diet + pH 5.2% brewed vinegar (1ml / kg bw), HD-PV1 is a high fat diet + 5.2% persimmon vinegar (1ml / kg bw), HD-PV2 shows high fat diet + acidity 5.2% persimmon vinegar (2 ml / kg bw).

표 1. 식이 조성Table 1. Dietary Composition

IngredientIngredient ControlControl Persimmons VinegarPersimmons vinegar HD1 ) HD 1 ) HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Casein, 80 MeshCasein, 80 Mesh 200200 200200 200200 200200 L-cystineL-cystine 33 33 33 33 Corn StarchCorn starch 00 00 00 00 Maltodextrin 10Maltodextrin 10 125125 125125 125125 125125 SucroseSucrose 68.868.8 68.868.8 68.868.8 68.868.8 Cellulose, BW200Cellulose, BW200 5050 5050 5050 5050 Soybean OilSoybean oil 2525 2525 2525 2525 LardLard 245245 245245 245245 245245 Mineral Mix S10026Mineral Mix S10026 1010 1010 1010 1010 DiCalcium PhosphateDiCalcium Phosphate 1313 1313 1313 1313 Calcium CarbonateCalcium Carbonate 5.55.5 5.55.5 5.55.5 5.55.5 Potassium citrate, 1 H2OPotassium citrate, 1 H 2 O 16.516.5 16.516.5 16.516.5 16.516.5 Vitamin Mix V10001Vitamin Mix V10001 1010 1010 1010 1010 Choline BitartrateCholine bitartrate 22 22 22 22 FD&C Blue Dye #1FD & C Blue Dye # 1 0.050.05 0.050.05 0.050.05 0.050.05 Total (g)Total (g) 773.85773.85 773.85773.85 773.85773.85 773.85773.85 KcalKcal 40574057 40574057 40574057 40574057 Administration of Brewing VinegarAdministration of Brewing Vinegar -- 1㎖/㎏ BW1ml / kg BW -- -- Administration of Persimmon VinegarAdministration of Persimmon Vinegar -- -- 1㎖/㎏ BW1ml / kg BW 2㎖/㎏ BW2ml / kg BW

1) AIN-93 diet를 변형한 지방 35%를 함유하는 고지방식이(60% fat kcal).1) High-fat diet containing 60% fat modified from the AIN-93 diet (60% fat kcal).

[실시예 3] 식이 섭취량 조사Example 3 Dietary Intake Survey

식이 및 칼로리 섭취량은 모든 군에서 유의적인 차이를 보이지 않았다(표 2).Diet and calorie intake showed no significant difference in all groups (Table 2).

표 2. 식이 및 칼로리 섭취량Table 2. Diet and Calorie Intake

ControlControl Persimmons VinegarPersimmons vinegar HDHD HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Feed consumption (g/d)Feed consumption (g / d) 2.52±0.061) 2.52 ± 0.06 1) 2.24±0.042.24 ± 0.04 2.45±0.132.45 ± 0.13 2.22±0.112.22 ± 0.11 Energy intake (kcal/d)Energy intake (kcal / d) 13.10±0.2913.10 ± 0.29 11.62±0.1811.62 ± 0.18 12.74±0.6612.74 ± 0.66 11.52±0.5511.52 ± 0.55

1) 모든 값은±표준편차(n=32). 1) All values are ± standard deviation (n = 32).

[실시예 4] 체중 증가량 조사Example 4 Investigation of Weight Gain

전체 체중 증가량은 표 3에 나타낸 바와 같이 모든 군에서 유의적인 차이를 보이지 않았다(표 3).The total weight gain did not show a significant difference in all groups as shown in Table 3 (Table 3).

표 3. 체중 변화Table 3. Weight Change

ControlControl Persimmons VinegarPersimmons vinegar HDHD HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Initial weight (g)Initial weight (g) 41.33±4.331) 41.33 ± 4.33 1) 41.29±3.1441.29 ± 3.14 42.48±5.8142.48 ± 5.81 40.53±4.1740.53 ± 4.17 Weight gain (g)Weight gain (g) 6.90±2.596.90 ± 2.59 7.01±1.417.01 ± 1.41 7.83±1.587.83 ± 1.58 9.32±1.159.32 ± 1.15

1) 모든 값은±표준편차(n=32). 1) All values are ± standard deviation (n = 32).

[실시예 5] 복부 지방 증가량 조사Example 5 Investigation of Abdominal Fat Increase

HD군과 비교시 식초를 투여한 모든 군에서 유의적으로 복부 지방이 감소하였으며, HD-PV1군이 가장 낮은 증가량을 보였다(표 4).Compared with the HD group, abdominal fat was significantly decreased in all groups treated with vinegar, and the HD-PV1 group showed the lowest increase (Table 4).

표 4. 복부 지방 변화Table 4. Abdominal Fat Changes

ControlControl Persimmons VinegarPersimmons vinegar HDHD HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Abdominal Fat (g)Abdominal Fat (g) 2.65±0.271) a2 ) 2.65 ± 0.27 1) a2 ) 2.17±0.27b 2.17 ± 0.27 b 1.56±0.27c 1.56 ± 0.27 c 2.13±0.25b 2.13 ± 0.25 b Abdominal Fat (%)Abdominal Fat (%) 5.66±0.57a 5.66 ± 0.57 a 4.70±0.91b 4.70 ± 0.91 b 3.17±0.61c 3.17 ± 0.61 c 4.64±0.59b 4.64 ± 0.59 b

1) 모든 값은±표준편차(n=32). 1) All values are ± standard deviation (n = 32).

2) 동일한 줄에 다른 위첨자의 값은 유의적으로 차이가 있다(p<0.05). 2) The values of other superscripts on the same line are significantly different (p <0.05).

[실시예 6] 고산 감식초의 생리기능성 평가Example 6 Evaluation of Physiological Functionality of Alpine Persimmon Vinegar

17주간 흰쥐를 사육한 후 희생시켜 항비만 효과를 실험하였다. 혈중 및 간중의 지질 성상조사, 혈중 및 간중의 Carnitine 함량을 통한 에너지 대사를 분석하였다. 하기에서, HD는 고지방식이, HD-V는 고지방식이+산도 5.2% 양조식초(1㎖/kg b.w.), HD-PV1은 고지방식이+산도 5.2% 감식초(1㎖/kg b.w.), HD-PV2는 고지방식이+산도 5.2% 감식초(2㎖/㎏ b.w.)를 나타낸다. Rats were bred for 17 weeks and sacrificed for their anti-obesity effects. The lipid profile of blood and liver, and energy metabolism through carnitine content in blood and liver were analyzed. In the following, HD is a high fat diet, HD-V is a high fat diet + pH 5.2% brewed vinegar (1ml / kg bw), HD-PV1 is a high fat diet + 5.2% persimmon vinegar (1ml / kg bw), HD-PV2 shows high fat diet + acidity 5.2% persimmon vinegar (2 ml / kg bw).

카르니틴 함량을 조사하기 위해 NEC(Nonesterified carnitine), ASAC(Acidsoluble acylcarnitine), AIAC(Acidinsoluble acylcarnitine) 및 Acyl/Free((ASAC+AIAC)/NEC)를 측정하였다. To investigate carnitine content, NEC (Nonesterified carnitine), ACAC (Acidsoluble acylcarnitine), AIAC (Acidinsoluble acylcarnitine) and Acyl / Free ((ASAC + AIAC) / NEC) were measured.

(1) 혈중 지질 농도 조사 (1) Blood lipid concentration investigation

고지방식이로 인해 높아진 혈중 중성지질, 혈중 총콜레스테롤 및 혈중 LDL-콜레스테롤 농도는 모든 식초 투여군에서 유의적으로 낮아졌다. 또한, HDL-콜레스테롤은 HD군 및 HD-V군과 비교시 유의적으로 높은 값을 보였다(표 5).High triglycerides, total cholesterol and blood LDL-cholesterol levels were significantly lower in all vinegar groups. In addition, HDL-cholesterol showed a significantly higher value than the HD group and HD-V group (Table 5).

표 5. 혈중 지질 농도Table 5. Blood Lipid Concentrations

ControlControl Persimmons VinegarPersimmons vinegar HDHD HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Triglyceride (㎎/㎗)Triglyceride (mg / ㎗) 96.06±1.971) a2 ) 96.06 ± 1.97 1) a2 ) 65.81±20.30b 65.81 ± 20.30 b 55.75±18.03b 55.75 ± 18.03 b 62.05±11.19b 62.05 ± 11.19 b Total cholesterol (㎎/㎗)Total cholesterol (mg / ㎗) 175.94±9.47a 175.94 ± 9.47 a 146.79±23.75ab 146.79 ± 23.75 ab 137.17±28.38b 137.17 ± 28.38 b 143.18±13.05ab 143.18 ± 13.05 ab HDL-c (㎎/㎗)HDL-c (mg / dl) 109.50±21.11c 109.50 ± 21.11 c 115.58±22.54bc 115.58 ± 22.54 bc 138.46±24.70ab 138.46 ± 24.70 ab 142.81±6.38a 142.81 ± 6.38 a LDL-c (㎎/㎗)LDL-c (mg / dl) 76.50±7.56a 76.50 ± 7.56 a 40.75±16.00b 40.75 ± 16.00 b 31.20±17.86b 31.20 ± 17.86 b 24.73±20.31b 24.73 ± 20.31 b

1) 모든 값은±표준편차(n=32). 1) All values are ± standard deviation (n = 32).

2) 동일한 줄에 다른 위첨자의 값은 유의적으로 차이가 있다(p<0.05). 2) The values of other superscripts on the same line are significantly different (p <0.05).

(2) 간중 지질 농도 조사(2) Liver lipid concentration investigation

간중 지질 성상 중 중성지방 및 총콜레스테롤 농도는 모든 감식초 투여군에서 유의적으로 낮았으며 감식초 투여군 간의 유의적 차이는 없었다. 또한, HD-PV2군의 총콜레스테롤 농도는 HD군 및 HD-V군과 비교시 유의적으로 낮아졌다(표 6).The triglyceride and total cholesterol concentrations in liver were significantly lower in all groups of persimmon vinegar and there was no significant difference between groups. In addition, the total cholesterol concentration of the HD-PV2 group was significantly lower compared to the HD group and HD-V group (Table 6).

표 6. 간중 지질 농도Table 6. Liver Lipid Concentration

ControlControl Persimmons VinegarPersimmons vinegar HDHD HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Triglyceride (㎎/g)Triglyceride (mg / g) 37.86±15.081) a2 ) 37.86 ± 15.08 1) a2 ) 27.68±6.92ab 27.68 ± 6.92 ab 22.98±6.86b 22.98 ± 6.86 b 23.80±5.55b 23.80 ± 5.55 b Total cholesterol (㎎/g)Total cholesterol (mg / g) 2.00±0.73a 2.00 ± 0.73 a 1.89±0.43ab 1.89 ± 0.43 ab 1.12±0.65bc 1.12 ± 0.65 bc 0.91±0.47c 0.91 ± 0.47 c

1) 모든 값은±표준편차(n=32). 1) All values are ± standard deviation (n = 32).

2) 동일한 줄에 다른 위첨자의 값은 유의적으로 차이가 있다(p<0.05). 2) The values of other superscripts on the same line are significantly different (p <0.05).

(3) 혈중 카르니틴 함량 조사(3) Investigation of blood carnitine content

혈중 AIAC(Acidinsoluble acylcarnitine) 함량은 HD군과 비교했을 때 HD-V군과 HD-PV1군에서 유의적으로 높았으며 총카르니틴, NEC(Nonesterified carnitine), ASAC(Acidsoluble acylcarnitine) 및 Acyl/Free ratio는 유의적인 차이를 보이지 않았다(표 7).Blood AIAC (Acidinsoluble acylcarnitine) content was significantly higher in HD-V and HD-PV1 group than in HD group. There was no statistical difference (Table 7).

표 7. 혈중 카르니틴 함량Table 7. Blood Carnitine Content

ControlControl Persimmons VinegarPersimmons vinegar HDHD HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Total carnitine (umol/㎗)Total carnitine (umol / ㎗) 2.04±0.412.04 ± 0.41 2.10±0.292.10 ± 0.29 2.13±0.552.13 ± 0.55 1.84±0.231.84 ± 0.23 NEC (umol/㎗)NEC (umol / ㎗) 0.56±0.060.56 ± 0.06 0.57±0.120.57 ± 0.12 0.73±0.250.73 ± 0.25 0.61±0.200.61 ± 0.20 ASAC (umol/㎗)ASAC (umol / ㎗) 1.26±0.321.26 ± 0.32 1.25±0.271.25 ± 0.27 1.13±0.611.13 ± 0.61 1.03±0.211.03 ± 0.21 AIAC (umol/㎗)AIAC (umol / ㎗) 0.16±0.04b 0.16 ± 0.04 b 0.28±0.08a 0.28 ± 0.08 a 0.27±0.04a 0.27 ± 0.04 a 0.20±0.06ab 0.20 ± 0.06 ab Acyl/Free(%)Acyl / Free (%) 2.65±0.552.65 ± 0.55 2.89±1.272.89 ± 1.27 2.16±1.192.16 ± 1.19 2.21±0.912.21 ± 0.91

1) 모든 값은±표준편차(n=32). 1) All values are ± standard deviation (n = 32).

2) 동일한 줄에 다른 위첨자의 값은 유의적으로 차이가 있다(p<0.05). 2) The values of other superscripts on the same line are significantly different (p <0.05).

(4) 간중 카르니틴 (4) carnitine in liver

간중 AIAC(Acidinsoluble acylcarnitine) 함량은 HD군 및 HD-V군과 비교했을 때, HD-PV2군에서 유의적으로 높았으며 총카르니틴, NEC(Nonesterified carnitine), ASAC(Acidsoluble acylcarnitine) 및 Acyl/Free ratio는 유의적인 차이를 보이지 않았다(표 8).Acidinsoluble acylcarnitine (AIAC) content in liver was significantly higher in HD-PV2 group than in HD group and HD-V group. There was no significant difference (Table 8).

표 8. 간중 카르니틴 함량Table 8. Carnitine Content in Liver

ControlControl Persimmons VinegarPersimmons vinegar HDHD HD-VHD-V HD-PV1HD-PV1 HD-PV2HD-PV2 Total carnitine (nmol/g)Total carnitine (nmol / g) 121.83±29.75121.83 ± 29.75 132.34±46.92132.34 ± 46.92 135.54±32.34135.54 ± 32.34 131.98±39.75131.98 ± 39.75 NEC (nmol/g)NEC (nmol / g) 64.79±23.5564.79 ± 23.55 69.32±21.7869.32 ± 21.78 62.96±43.8362.96 ± 43.83 66.10±19.6166.10 ± 19.61 ASAC (nmol/g)ASAC (nmol / g) 52.46±29.0352.46 ± 29.03 56.95±29.3656.95 ± 29.36 63.81±13.8463.81 ± 13.84 51.72±31.6551.72 ± 31.65 AIAC (nmol/g)AIAC (nmol / g) 5.16±2.77b 5.16 ± 2.77 b 6.07±3.97b 6.07 ± 3.97 b 8.77±4.96ab 8.77 ± 4.96 ab 14.17±8.66a 14.17 ± 8.66 a Acyl/Free(%)Acyl / Free (%) 0.99±0.520.99 ± 0.52 0.92±0.320.92 ± 0.32 2.74±3.992.74 ± 3.99 1.07±0.541.07 ± 0.54

1) 모든 값은±표준편차(n=32). 1) All values are ± standard deviation (n = 32).

2) 동일한 줄에 다른 위첨자의 값은 유의적으로 차이가 있다(p<0.05). 2) The values of other superscripts on the same line are significantly different (p <0.05).

NEC; Nonesterified carnitine. ASAC; Acidsoluble acylcarnitine. AIAC; Acidinsoluble acylcarnitine. Acyl/Free; (ASAC+AIAC)/NEC.NEC; Nonesterified carnitine. ASAC; Acidsoluble acylcarnitine. AIAC; Acidinsoluble acylcarnitine. Acyl / Free; (ASAC + AIAC) / NEC.

(5) 공복시 혈당 변화(5) changes in fasting blood sugar

5주, 7주, 9주 및 11주에 4시간 공복 후 혈당을 조사하였다. HD군과 비교시 모든 투여 실험군에서 유의적으로 낮은 혈당 수치를 보였다(도 1). Blood glucose levels were examined after fasting for 4 hours at 5, 7, 9 and 11 weeks. Compared with the HD group, all the administration groups showed significantly lower blood glucose levels (FIG. 1).

(6) 경구 당 부하 검사(6) oral sugar load test

공복시에는 군 간의 유의적인 차이가 없었으나, 포도당 부하 후 30분부터 60분까지 모든 군과 비교시 HD-PV1군에서 유의적으로 낮은 값을 보였다(도 2).There was no significant difference between the groups on an empty stomach, but significantly lower values in the HD-PV1 group compared to all groups from 30 minutes to 60 minutes after glucose loading (FIG. 2).

이상에서 살펴본 바와 같이 식이 섭취량, 칼로리 섭취량 및 전체 체중 증가량은 모든 군에서 유의적인 차이를 보이지 않았으나, HD군과 비교시 식초를 투여한 모든 군에서 유의적으로 복부 지방이 감소하였으며, HD-PV1군이 가장 낮은 증가량을 보였다. 고지방식이로 인해 높아진 혈중 중성지질, 혈중 총콜레스테롤, 혈중 LDL-콜레스테롤, 간중 중성지방 및 간중 총콜레스테롤 농도는 모든 식초 투여군에서 유의적으로 낮아졌다. 특히, 혈중 HDL-콜레스테롤은 HD군 및 HD-V군과 비교시 유의적으로 높은 값을 보였으며, 간중 HD-PV2군의 총콜레스테롤 농도는 HD군 및 HD-V군과 비교시 유의적으로 낮아졌다.As mentioned above, dietary intake, calorie intake and total weight gain were not significantly different in all groups, but significantly decreased abdominal fat in all groups treated with vinegar compared to HD group and HD-PV1 group. This showed the lowest increase. Elevated serum triglycerides, total cholesterol, blood LDL-cholesterol, hepatic triglycerides and hepatic total cholesterol levels were significantly lowered in all vinegar groups. In particular, blood HDL-cholesterol was significantly higher than the HD and HD-V groups, and total cholesterol concentration in the HD-PV2 group in the liver was significantly lower than the HD and HD-V groups. .

또한, 혈중 및 간중의 AIAC(Acidinsoluble acylcarnitine) 함량은 HD군과 비교했을 때 HD-PV1군과 HD-PV2군에서 각각 유의적으로 높았다.In addition, AIAC (Acidinsoluble acylcarnitine) content in blood and liver was significantly higher in HD-PV1 and HD-PV2 groups than HD group.

경구 당 부하 검사에서는 포도당 부하 후 30분부터 60분까지 모든 군과 비교시 HD-PV1군에서 유의적으로 낮은 값을 보였다.In the oral glucose loading test, the HD-PV1 group was significantly lower than the 30-60 minutes after glucose loading.

이상에서 살펴본 바와 같이 본 발명의 알코올 발효와 초산발효의 2단 발효법에 의해 얻은 항비만용 감식초는 복부 지방을 감소시키고, 혈중 콜레스테롤 및 혈 당을 감소시키는 기능이 있으므로, 비만을 효과적으로 억제하거나 예방하기 위한 식품으로 이용할 수 있다. As described above, the antiobesity persimmon vinegar obtained by the alcoholic fermentation and acetic acid fermentation two-stage fermentation method has a function of reducing abdominal fat and reducing blood cholesterol and blood sugar, thereby effectively preventing or preventing obesity. Can be used as food for.

Claims (4)

삭제delete 삭제delete 삭제delete 감분쇄물에 대하여 사카로마이세스 베이아누스 효모를 1~10중량%, 펙티나아제를 30~80 ppm 및 설탕을 첨가하는 단계;Adding 1 to 10% by weight of Saccharomyces Beyanus yeast, 30 to 80 ppm of pectinase and sugar relative to the ground matter; 실온에서 10~14시간 동안 효소 반응을 수행하는 단계;Performing an enzyme reaction at room temperature for 10-14 hours; 공기를 차단한 상태로 24~26℃에서 3~10일 동안 알코올 발효하는 단계; Alcohol fermentation at 24 to 26 ° C. for 3 to 10 days while blocking air; 15℃ 전후의 온도에서 1~2개월 동안 숙성시키는 단계; 및Aging for 1 to 2 months at a temperature of about 15 ℃; And 상기 알코올 발효액을 여과하여 얻어진 발효액에 초산균을 함유한 감식초를 1~10중량% 첨가하여 15~20℃에서 30~45일 동안 초산발효하는 단계를 통해 얻은 감식초를 함유하는 건강 기능성 음료.Health functional beverage containing persimmon vinegar obtained through the step of acetic acid fermentation at 15 ~ 20 ℃ 30 ~ 45 days by adding 1 ~ 10% by weight of persimmon vinegar containing acetic acid bacteria to the fermentation broth obtained by filtering the alcohol fermentation broth.
KR1020060061065A 2006-06-30 2006-06-30 Functional beverage containing persimmon vinegar KR100767802B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060061065A KR100767802B1 (en) 2006-06-30 2006-06-30 Functional beverage containing persimmon vinegar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060061065A KR100767802B1 (en) 2006-06-30 2006-06-30 Functional beverage containing persimmon vinegar

Publications (1)

Publication Number Publication Date
KR100767802B1 true KR100767802B1 (en) 2007-10-18

Family

ID=38815014

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060061065A KR100767802B1 (en) 2006-06-30 2006-06-30 Functional beverage containing persimmon vinegar

Country Status (1)

Country Link
KR (1) KR100767802B1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101268431B1 (en) * 2010-10-15 2013-05-28 경북대학교 산학협력단 Method of producing health-benefit fermented persimmon products by persimmon peel
KR101446528B1 (en) * 2012-01-20 2014-11-04 의성농산영농조합법인 Vinegar Composition Fermented with Black Garlic and Preparation Method Thereof
CN104774738A (en) * 2015-04-29 2015-07-15 合肥不老传奇保健科技有限公司 Persimmon and wild jujube aged fruit vinegar and making method thereof
KR20160093876A (en) * 2015-01-30 2016-08-09 김연길 the manufacture method of persimmon vinegar
CN106635731A (en) * 2016-12-21 2017-05-10 陕西时代酿造科技有限公司 Preparation method for persimmon vinegar

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980002239A (en) * 1997-10-22 1998-03-30 곽영주 Persimmon Vinegar Manufacturing Method
KR0151732B1 (en) * 1995-04-20 1998-09-15 김강권 Method for preparing persimmon vinegar

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0151732B1 (en) * 1995-04-20 1998-09-15 김강권 Method for preparing persimmon vinegar
KR980002239A (en) * 1997-10-22 1998-03-30 곽영주 Persimmon Vinegar Manufacturing Method

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101268431B1 (en) * 2010-10-15 2013-05-28 경북대학교 산학협력단 Method of producing health-benefit fermented persimmon products by persimmon peel
KR101446528B1 (en) * 2012-01-20 2014-11-04 의성농산영농조합법인 Vinegar Composition Fermented with Black Garlic and Preparation Method Thereof
KR20160093876A (en) * 2015-01-30 2016-08-09 김연길 the manufacture method of persimmon vinegar
KR101717341B1 (en) 2015-01-30 2017-03-16 김연길 the manufacture method of persimmon vinegar
CN104774738A (en) * 2015-04-29 2015-07-15 合肥不老传奇保健科技有限公司 Persimmon and wild jujube aged fruit vinegar and making method thereof
CN106635731A (en) * 2016-12-21 2017-05-10 陕西时代酿造科技有限公司 Preparation method for persimmon vinegar

Similar Documents

Publication Publication Date Title
KR101301094B1 (en) Composition for relieving hangover or improving liver function
JP2009013123A (en) Health-retaining preparation
KR100852416B1 (en) Cucurbitaceae vinegar composition
KR20170017142A (en) Functional Gochujang Having Antioxidant Activity and Whitening Effects and Manufacturing Method Thereof
KR100767802B1 (en) Functional beverage containing persimmon vinegar
TWI430754B (en) Process for producing γ-aminobutyric acid-rich material
JP5120553B2 (en) Health drink
KR101261029B1 (en) Composition for preventing or improving the diabete containing suaeda japonica
KR101716297B1 (en) Method drinks for prevent a metabolic syndrome that made by Hericium erinaceus extracts containing crude drugs extracts.
KR102326568B1 (en) Method of making the oarts mkgeolli using oats with bran and buckwheat chaff
KR102168192B1 (en) Healthful mixed tea development using fermented herbs, fruits and shiitake
KR101509796B1 (en) Composition for preventing or treating obesity comprising blueberry fermentation extract
Haghighi et al. Designing an all‐apple‐pomace‐based functional dessert formulation
KR101979001B1 (en) Composition for the effect of suppressing the elevation of blood sugar level having extract of peanut sprouts as active component
KR101350046B1 (en) Vinegar composition fermented with herbal extracts and preparation method thereof
KR20190140737A (en) Vinegar compositions comprising detox-diet material and manufacturing method thereof
KR100994196B1 (en) Method of preparing fermented liquid of garlic and chonggugjang
KR100948391B1 (en) Korean hot pepper paste of citrus fruits comprising concentration liquid of citrus fruits and preparation method of thereof
KR102294897B1 (en) manufacturing method of fermented food
KR101925124B1 (en) Manufacturing method for fermented drink using vegetable sourse
CN111202197A (en) Preparation method of highland barley fermented beverage and highland barley fermented beverage prepared by same
JP2006265142A (en) Body fat accumulation inhibiting or decreasing agent
KR102501329B1 (en) Method for processing plum with improved anti-cancer activity, anti-diabetes activity and effectiveness in improving blood lipid and processed plum using the same
KR102457306B1 (en) Health function food composition comprising lactobacillus for improving skin and vowel function and method of preparing the same
KR102587601B1 (en) Method for manufacturing coffee makgeolli including coffee, oats and buckwheat hull liquid fermented liquid, and coffee makgeolli produced thereby

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Publication of correction
FPAY Annual fee payment

Payment date: 20121010

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20131008

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20141008

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20151104

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20161010

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20171012

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20180723

Year of fee payment: 12

R401 Registration of restoration